Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02134015
Title Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Daiichi Sankyo Inc., Parexel
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | ESP | DEU | CAN | BEL


No variant requirements are available.